After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Knowing when to reassess your financial plan is key to success. Stay informed about the right times to make adjustments.
23,689 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Investors chase value, momentum and income as markets wobble in July 2026. This report breaks down the retirement por...
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
Small-cap stocks are delivering the sharpest outperformance versus the S&P 500 in years, with a roughly 20% YTD g...
Booking Holdings trades at elevated levels, reigniting debate over whether a stock split could broaden retail ownersh...
Remote work demand worldwide is shifting how companies hire, spend, and allocate capital. This in-depth guide breaks ...
Bitcoin reclaims the $70,000 level as macro tensions and a large options stack around the strike drive hedging flows....
Institutional demand is reshaping crypto markets as investors lean on options to define risk on large Bitcoin positio...
The White House suspended the Jones Act for 60 days to ease shipping and energy market pressures amid regional confli...
Nike has faced a decades-long love-hate relationship with investors: the brand remains powerful, but the stock has sl...
A crypto-fueled donation story puts UK election rules under a microscope. Reform UK’s Farage claims there’s no obliga...
HOA governance risk is reshaping due diligence for homebuyers. This report explains what real estate agents should sc...